NCT07320274 (Arc-FIT) is a NA clinical trial of ArcFlex Sheath in Valve Disease, Aortic, sponsored by Sun Yat-sen University.

Who is sponsoring NCT07320274?

NCT07320274 is sponsored by Sun Yat-sen University.

What drugs are being tested in NCT07320274?

Interventions in NCT07320274: ArcFlex Sheath, ordinary sheath.

What condition does NCT07320274 study?

NCT07320274 studies Valve Disease, Aortic.

Is NCT07320274 still recruiting?

NCT07320274 is currently not yet recruiting. Last updated 6 January 2026.

Last reviewed 2026-01-06 · How we verify

NCT07320274: Arc-FIT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ArcFlex Sheath in TAVR Trial

Not yet recruiting NA Last updated 6 January 2026

What this trial tests

NA trial testing ArcFlex Sheath in Valve Disease, Aortic in 180 participants. Not yet recruiting.

Timeline

1 March 2026

Primary endpoint
30 December 2028

30 March 2030

Quick facts

Lead sponsor	Sun Yat-sen University
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	180
Start date	1 March 2026
Primary completion	30 December 2028
Estimated completion	30 March 2030
Sites	1 location across China

Drugs / interventions tested

ArcFlex Sheath
ordinary sheath

Conditions studied

Valve Disease, Aortic — all drugs for Valve Disease, Aortic →

Sponsor

Sun Yat-sen University

Who can join

Eligibility, any sex, with Valve Disease, Aortic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

TAVR is a crucial treatment method for aortic valve diseases. The requirements for the device to cross the aortic arch and for the bioprosthetic valve to be coaxial are quite high, and they are key steps for the success of the surgery. Investigators' aim is to evaluate the safety and effectiveness of a variable-bend sheath for the TAVR procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Valve Disease, Aortic

Currently open trials in the same condition.

NCT07197736 — DELINEATE-Prospective · recruiting
NCT06387446 — Allogeneic Valve Transplantation · NA · recruiting
NCT06449469 — The Nordic Aortic Valve Intervention Trial 4 (NOTION-4) · NA · active not recruiting

Other Sun Yat-sen University trials

Trials by the same sponsor.

NCT07255612 — Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negat · Phase 2 · not yet recruiting
NCT07371897 — Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial · Phase 3 · not yet recruiting
NCT07489703 — SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC · Phase 2 · not yet recruiting
NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
NCT07522281 — Evaluation of an Undisturbed Embryo Culture System for Embryo Development in IVF/ICSI Cycles · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07320274 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sun Yat-sen University
Last refreshed: 6 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07320274.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing